OPEN END TURBO LONG - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 03:19:43 2024-07-09 pm EDT | ||
| 0.39 EUR | +21.88% |
|
| Current month | -13.33% | ||
| 1 month | -13.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-07-09 | 0.39 | +21.88% |
| 24-07-08 | 0.32 | +6.67% |
| 24-07-05 | 0.3 | -14.29% |
| 24-07-04 | 0.35 | +9.37% |
| 24-07-03 | 0.32 | -11.11% |
Delayed Quote Börse Stuttgart
Last update July 09, 2024 at 03:19 pm EDT
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Morgan Stanley |
| WKN | MB9YCM |
| ISIN | DE000MB9YCM4 |
| Date issued | 2023-08-21 |
| Strike | 36.51 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.5 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.55 € |
|---|---|
| Lowest since issue | 0.29 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.86
USD
Average target price
53.19
USD
Spread / Average Target
+30.19%
- Stock Market
- Certificates
- Certificat
